| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, Hôpital St Roch, Nice, France
Address correspondence and reprint requests to Michel Carles, MD, Département dAnesthésie-Réanimation, Hôpital St Roch 5 rue Pierre Dévoluy 06006 Nice cédex 1, France. Address e-mail to michel.carles{at}biosys.net
| Abstract |
|---|
|
|
|---|
Implications: We prospectively evaluated the feasability and the factors causing failure of a peripheral nerve block technique (humeral block) using neurostimulation in a large number of patients. The importance of the level of stimulation for the success of the block was evaluated for the first time.
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
Blood pressure, oxygen saturation monitoring, and a peripheral venous access were done before the beginning of the anesthetic procedure. After premedication with midazolam 5 mg sublingually administered 1 h before the arrival in the operating room and midazolam 1 mg IV bolus for sedation to reach a Ramsay score of 2 (cooperating, oriented, and still patient), humeral blocks were performed on all patients while they were in a supine position. Upper limbs were positioned in abduction (80°), and external rotation and the course of the brachial artery on the medial side of the arm was marked. A BraunTM neurostimulator with a 22-gauge 50-mm needle was used for all patients (Stimuplex® B-Braun, Melsungen AG, Germany). The puncture site was at the junction between the upper and middle thirds of the arm, immediately above the brachial artery. The needle was introduced following the direction of the brachial artery, toward the axilla. After crossing the brachial fascia, the neurostimulator was started. The initial current was 3 mA, rapidly decreased when motor response was noted. Nerve location was performed in the following order: median, ulnar, radial, and musculocutaneous, according to the initial description (2). After reaching the minimal level for each nerve stimulation with an adequate motor response, an aspiration test was done and finally, 810 mL of anesthetic solution was injected for each of the three nerves: median, radial, and ulnar. For the musculocutaneous nerve, 68 mL of solution was injected and 24 mL for the medial cutaneous nerve. The usual anesthetic solution injected contained 1.5% lidocaine with epinephrine (1:200,000) in combination with an opioid (sufentanil or nalbuphine), and with clonidine if required to prolong the block duration.
The gathered data included age, weight, sex, ASA physical status, surgical procedures, training level of anesthesiologists for this technique (recognized as experienced if at least 50 humeral blocks had been performed and considered as inexperienced if in training), anesthetic solution, time between humeral block and surgical incision, duration of surgery, threshold level reached for each nerve with the injection of the anesthetic solution, and volume injected for each nerve. Adverse events were noted during humeral block or surgery, and block failure was defined as the absence of sensory block in at least one neural distribution and/or the need of another anesthetic technique to allow surgery. The sensory block was evaluated by sensitivity to cold (ether test).
To evaluate the time spent while performing the humeral block and the delay for the anesthetic solution to become effective, a subgroup of patients was studied. Over a period of 4 mo (October 1997January 1998), only the patients anesthetized by an "experienced" anesthesiologist (as defined) using the same anesthetic technique (40 mL of 1.5% lidocaine with epinephrine 1:200,000 and sufentanil 25 µg) were included. The procedure time was measured between the skin puncture and the withdrawal of the needle; the onset period was measured between the end of the humeral block (withdrawal of the needle) and a complete sensory block in each neural distribution (ether test). A physical examination was planned at 1 mo for all patients to detect adverse neurological events.
Results are expressed as mean ± SD and range. The analysis of data was performed with EpiInfoTM software (Centers for Disease Control, Atlanta, GA). Relative risk (RR) with 95% confidence interval (CI95) evaluated by series of Taylor,
2, Fishers exact test, analysis of variance, and Kruskall-Wallis nonparametric analysis were used if required. Relative risk of failure was expressed as RRf, indicating for each level of stimulation the calculated RR with CI95. A value of P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
|
The threshold of stimulation used to locate the nerve before injecting the anesthetic solution was found to be a predictive factor of failure (Figure), with a threshold value of 0.8 mA for the median nerve (RRf 1.49, P = 0.04), 0.6 mA for the radial nerve (RRf 1.3, P = 0.02), and 0.7 mA for the ulnar nerve (RRf 1.36, P = 0.04). For any injection using this intensity of stimulation or higher, the risk of failure of humeral block increased. With a stimulation level
1 mA, RRf was always at least 4 times more than the success rate of humeral block. For the musculocutaneous nerve, we did not find a minimum threshold stimulation representative of the risk of failure, although beyond 0.7 mA the RRf was always more than 1.3.
|
Complications were more frequent with an anesthesiologist not trained to this technique than with a trained specialist (9% versus 6%, P = 0.03). Even if complications such as nausea and vomiting, which can be attributed to the adjunctive therapy, were excluded, the difference remained significant (5% versus 3%, P = 0.02).
During the 1-mo follow-up (1247 surveyed patients representing 85% of the patients), hematomas were reported in 3% of cases at the puncture site of the humeral block in the first 10 days after surgery. There were no cases of persisting paresthesia and no other adverse events requiring further investigation.
| Discussion |
|---|
|
|
|---|
The success rate of this technique is good (95%), even for anesthesiologists with no training (94%); these results are in agreement with those of Dupré (2). Compared with other approaches to the brachial plexus (mostly the axillary block using the transarterial approach or neurostimulation) having the same indications for upper limb surgery (1), the success rate of this procedure is better (8). Indeed, for the axillary block, Schroeder et al. (9) report a success rate of 89%, reaching 94% when combining the transarterial approach, neurostimulation, and eliciting paresthesia. Urban and Urquhart (10) report 93% of successful blocks using the transarterial approach or by eliciting paresthesia. Finally, Stan et al. (5), obtained a complete block in 89% of cases in a series of 1000 patients having an axillary block using the transarterial approach.
The average time spent to perform the humeral block was 10 minutes. This short delay is well adapted to ambulatory or emergency surgery. After the humeral block has been performed, the mean time for completion of the sensory block in all neural distributions was 15 minutes. Thus, for an anesthetic solution including 1.5% lidocaine with epinephrine, a minimal time interval of 25 minutes is required between the beginning of humeral block and the surgical incision. The order in which nerve blocks are achieved depends on the time required for the block to become effective. This delay is related to specific nerve characteristics: diameter and length of nerves and nerve fiber type (11). In our experience, the order should be the median nerve first for anatomical reasons (it is the most superficial) and because the delay for sensory block is the longest. The musculocutaneous nerve and the medial cutaneous nerve should be the last to be blocked because the delay of block is very short, confirmed by recently published data (6).
Failure is not linked to the experience of the anesthesiologist, to the physical characteristics of patients, or to the injected volume. Indeed, a total volume of 3840 mL is sufficient to insure a complete sensory block of the four nerves. A smaller volume may result in a sensory block of poorer quality in some nerve distributions (12).
Anatomical considerations and the use of neurostimulation are two important variables to reduce the risk of failure. The most frequent stimulation failures have occurred with the ulnar and the radial nerves. These facts are in agreement with the anatomical knowledge on variations in the location of the radial nerve and the possibility of a Martin Gruber anastomosis (the main neural anastomosis at this level [i.e., humeral canal] between the median and ulnar nerves, with a motor response of ulnar type after the stimulation of the median nerve) that may make it harder to locate the ulnar nerve by neurostimulation (2). As explained by other authors (13), the humeral block is not a "midhumeral block" but a block of the upper third-middle third junction of the arm. A too distal site of puncture can explain some stimulation failures on the radial nerve. Neurostimulation has allowed an anatomical approach to regional anesthesia, leading to a more reliable injection and a possibly decreased risk of nerve trauma (2,7). The level of stimulation is a predictive factor of failure. This is clearly demonstrated in our study for the three nerves: median, radial, and ulnar. A stimulation level under a threshold of 0.6 to 0.8 mA is recommended for the humeral block. Values under this threshold are associated with a high rate of success. The lack of relationship reported between failure and level of neurostimulation for the musculocutaneous nerve can be explained by its anatomical course along the humeral bone, within the brachial biceps muscle. Despite a too distant injection, a fast and wider diffusion of the anesthetic solution in the muscle can partially explain this fact. In our study, stimulation thresholds to avoid a failure caused by an injection too distant from the nerve, are in agreement with the data reporting an average stimulation level of 0.7 mA as a "reliable, consistent marker of needle tip proximity to the brachial plexus" (14).
The complication rate is low (7%). Adverse events are minor and often related to the side effects of opiates used in the anesthetic solution. No vascular puncture or intraneural injection and no paresthesias were observed, confirming the safety of this technique (2,6). Nevertheless, because of the possibility of occurrence of adverse events (6), a systematic investigation of signs or symptoms linked to neural or vascular injury is required. These results emphasize the use of neurostimulation compared with techniques relying on eliciting paresthesias or the transarterial approach carrying serious complications (paresthesia, regressive hematoma) (5,15). The two seizures observed during the humeral block occurred with a frequency of 1.3 in 1000 blocks. To avoid this type of complication, it is important to inject the anesthetics slowly (this was not done in the two cases). The infrequent incidence of major complications is also found in recent regional anesthesia literature (7,16).
Our study provides confirming information on the reliability and safety of this technique. In our study, stimulation thresholds were clinically evaluated for the first time and recognized as the main factor linked to the failure of a procedure using a neurostimulator. The humeral block is a reliable peripheral block giving good results with minor complications, even with untrained anesthesiologists. This technique offers the major advantage of a unique site of injection (humeral canal) to reach the four major nerves in the upper extremity in a selective approach. It opens the way to a more specific use of regional anesthesia, especially in ambulatory surgery because it provides postoperative analgesia targeted to the specific nerve distribution involved in the surgery, while obtaining a complete block of the upper limb during surgery (17). Excluding the usual contraindications, the humeral block is a peripheral block technique for upper limb surgery (with or without a tourniquet) representing an attractive alternative to the axillary block. According to our results, stimulation level is a good predictive criterion of failure.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Samson, V. Minville, C. Chassery, L. Nguyen, A. Pianezza, O. Fourcade, A. Rabinowitz, and K. Samii Eutectic Mixture of Local Anesthetic (EMLA(R)) Decreases Pain During Humeral Block Placement in Nonsedated Patients Anesth. Analg., August 1, 2007; 105(2): 512 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Brull, C. J. L. McCartney, V. W. S. Chan, and H. El-Beheiry Neurological Complications After Regional Anesthesia: Contemporary Estimates of Risk Anesth. Analg., April 1, 2007; 104(4): 965 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Escobar, E. A. Davis, J. Ehrenwerth, G. A. Watrous, G. S. Fisch, Z. N. Kain, and P. G. Barash Task Analysis of the Preincision Surgical Period: An Independent Observer-Based Study of 1558 Cases Anesth. Analg., October 1, 2006; 103(4): 922 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Voelckel, G. Klima, A. C. Krismer, C. Haslinger, K. H. Stadlbauer, V. Wenzel, and A. von Goedecke Signs of Inflammation After Sciatic Nerve Block in Pigs Anesth. Analg., December 1, 2005; 101(6): 1844 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Minville, L. N'Guyen, C. Chassery, P. Zetlaoui, J.-C. Pourrut, C. Gris, B. Eychennes, D. Benhamou, and K. Samii A Modified Coracoid Approach to Infraclavicular Brachial Plexus Blocks Using a Double-Stimulation Technique in 300 Patients Anesth. Analg., January 1, 2005; 100(1): 263 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Franco, V. Domashevich, G. Voronov, A. B. Rafizad, and T. J. Jelev The Supraclavicular Block with a Nerve Stimulator: To Decrease or Not to Decrease, That Is the Question Anesth. Analg., April 1, 2004; 98(4): 1167 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sia, A. Lepri, M. C. Campolo, and R. Fiaschi Four-Injection Brachial Plexus Block Using Peripheral Nerve Stimulator: A Comparison Between Axillary and Humeral Approaches Anesth. Analg., October 1, 2002; 95(4): 1075 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iskandar, E. Guillaume, F. Dixmerias, B. Binje, S. Rakotondriamihary, R. Thiebaut, and P. Maurette The Enhancement of Sensory Blockade by Clonidine Selectively Added to Mepivacaine After Midhumeral Block Anesth. Analg., September 1, 2001; 93(3): 771 - 775. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|